There are currently 85 clinical trials in Weston, Florida looking for participants to engage in research studies. Trials are conducted at various facilities, including Cleveland Clinic Florida, Cleveland Clinic-Weston, Cleveland Clinic Florida - Weston and Cleveland Clinic. Whether you're a healthy volunteer looking to participate in paid medical research or seeking trials related to a specific condition, the city provides a diverse range of opportunities near you.
Device Global Registry for the IlluminOss Bone Stabilization System
NCT05206981
Recruiting
This is a multi-center, observational patient registry. The primary objective of the study is to collect safety and performance data on the IlluminOss Device when used to provide stabilization and alignment for the treatment of traumatic or impending and pathologic fractures.
Gender:
All
Ages:
50 years and above
Trial Updated:
01/23/2024
Locations: Weston Outpatient Surgical Center, Weston, Florida
Conditions: Traumatic Fracture, Pathological Fracture
Register for Updates
Assessing the Benefit of Art & Music Therapy on Quality of Life in Patients With Breast Cancer
NCT04493034
Recruiting
This is a study of art-based and music-based therapy programs lasting three months (with additional follow-up 3 months after the end of the trial) in breast cancer patients currently receiving therapy as well as in cancer survivors.
Gender:
All
Ages:
18 years and above
Trial Updated:
01/02/2024
Locations: Cleveland Clinic Florida Weston, Case Comprehensive Cancer Center, Weston, Florida
Conditions: Breast Cancer
Register for Updates
CR845-310302: A Study to Evaluate the Safety and Efficacy of Difelikefalin in Advanced Chronic Kidney Disease Patients With Moderate-to-Severe Pruritus
NCT05356403
Recruiting
This is a multicenter, double-blind, randomized, placebo-controlled study to evaluate the safety and efficacy of oral difelikefalin administered as a 1 mg tablet once daily compared to placebo in reducing the intensity of itch in advanced chronic kidney disease (CKD) patients with moderate-to-severe pruritus. This study is comprised of an Efficacy Assessment Phase and a Long-term Extension Phase. The Efficacy Assessment Phase includes a double-blind 12-week Treatment Period (Treatment Period 1),... Read More
Gender:
All
Ages:
Between 18 years and 85 years
Trial Updated:
01/02/2024
Locations: Cara Therapeutics Study Site, Weston, Florida
Conditions: Chronic Kidney Diseases, Pruritus
Register for Updates
Multi-center Collaborative to Enhance Quality and Outcomes in the Management of Cardiogenic Shock
NCT05185492
Recruiting
This large real-world international prospective registry will provide a unique opportunity to comprehensively understand the contemporary management, clinical course and short as well as long-term outcomes of all Cardiogenic Shock (CS) patients cared for at four high volume dedicated shock care centers. As the first true North American multicenter CS collaborative with a uniform dedicated and comprehensive case report form, the high patient volumes and wide spectrum of clinical acuity seen at th... Read More
Gender:
All
Ages:
18 years and above
Trial Updated:
12/27/2023
Locations: Cleveland Clinic Florida, Weston, Florida
Conditions: Cardiogenic Shock, Acute Myocardial Infarction
Register for Updates
DORAYA-HF Early Feasibility Study
NCT05206422
Recruiting
The study objective is to evaluate the feasibility of the Doraya Catheter and measure clinical performance and safety endpoints, in ADHF patients deemed to have insufficient diuretic response.
Gender:
All
Ages:
18 years and above
Trial Updated:
12/25/2023
Locations: Cleveland Clinic, Weston, Florida
Conditions: Acute Decompensated Heart Failure
Register for Updates
Evaluating the Effectiveness of an Individualized Nutrition and Physical Activity Counseling Program
NCT04365569
Recruiting
More than 65% of breast cancer survivors are overweight and less than one-third participate in recommended levels of physical exercise. Obese breast cancer survivors have been found to have greater than a two-fold increase in mortality compared to women with normal body mass index (BMI). The current standard for weight loss interventions involves in-person counseling. However, this incurs costs related to travel for counseling sessions, potentially limiting program participation, compliance and... Read More
Gender:
Female
Ages:
18 years and above
Trial Updated:
12/19/2023
Locations: Cleveland Clinic Florida Weston, Case Comprehensive Cancer Center, Weston, Florida
Conditions: Breast Cancer
Register for Updates
Oral Ifetroban to Treat Diffuse Cutaneous Systemic Sclerosis (SSc) or SSc-associated Pulmonary Arterial Hypertension
NCT02682511
Recruiting
The purpose of this phase 2 multicenter, randomized, double-blind, placebo-controlled, study is to assess the safety and efficacy of ifetroban in patients with diffuse cutaneous systemic SSc (dcSSc) or SSc-associated pulmonary arterial hypertension (SSc-PAH).
Gender:
All
Ages:
Between 18 years and 80 years
Trial Updated:
12/13/2023
Locations: Cleveland Clinic - Florida, Weston, Florida
Conditions: Scleroderma, Diffuse, Scleroderma, Systemic, Scleroderma, Limited, Sclerosis, Progressive Systemic, Skin Diseases, Connective Tissue Diseases, Pathologic Processes, Autoimmune Diseases
Register for Updates
GORE® CARDIOFORM Septal Occluder and Antiplatelet Medical Management for Reduction of Recurrent Stroke in Patients With Patent Foramen Ovale (PFO): the REDUCE Post Approval Study
NCT03821129
Recruiting
This study will assess the safety and effectiveness of GORE® CARDIOFORM Septal Occluder in a post approval setting and evaluate the quality of operator education and training and transferability of trial experience to a post-market setting.
Gender:
All
Ages:
Between 18 years and 70 years
Trial Updated:
11/06/2023
Locations: Cleveland Clinic Florida, Weston, Florida
Conditions: Stroke, PFO - Patent Foramen Ovale
Register for Updates
Safety and Efficacy of TU-100 as an Adjunct to an Enhanced Recovery After Surgery in Subjects Undergoing Bowel Resection
NCT04742907
Recruiting
This multicenter, randomized, double-blinded, placebo-controlled study will evaluate the effect of TU-100 on resolution of postoperative ileus (POI) in subjects undergoing open or laparoscopic bowel resection (BR).
Gender:
All
Ages:
18 years and above
Trial Updated:
09/14/2023
Locations: Weston Site, Weston, Florida
Conditions: Enhanced Recovery After Surgery
Register for Updates
BAriatric Surgery Induced Chromosomal Change
NCT05903521
Recruiting
The purpose of this study is to better understand the impact of weight-loss surgery on telomere length. Telomeres are a key marker of biological aging of cells. Telomere shortening is a natural process of aging. Several pathologies and lifestyles are associated with premature telomere shortening, such as obesity, diabetes mellitus or sedentary lifestyle. New evidence supports that telomere shortening can be partially reversed by lifestyle changes such as healthy diet, reduced stress, or increase... Read More
Gender:
All
Ages:
18 years and above
Trial Updated:
09/14/2023
Locations: Cleveland Clinic Florida, Weston, Florida
Conditions: Obesity, Morbid
Register for Updates
Lung-MAP: A Master Screening Protocol for Previously-Treated Non-Small Cell Lung Cancer
NCT03851445
Recruiting
This screening and multi-sub-study randomized phase II/III trial will establish a method for genomic screening of similar large cancer populations followed by assigning and accruing simultaneously to a multi-sub-study hybrid Master Protocol (Lung-MAP). The type of cancer trait (biomarker) will determine to which sub-study, within this protocol, a participant will be assigned to compare new targeted cancer therapy, designed to block the growth and spread of cancer, or combinations to standard of... Read More
Gender:
All
Ages:
18 years and above
Trial Updated:
08/28/2023
Locations: Cleveland Clinic-Weston, Weston, Florida
Conditions: Previously Treated Non-Small Cell Lung Cancer
Register for Updates
HEMOTAG® Assessment for Short-term Outcomes of Heart Failure
NCT04149743
Recruiting
Evaluation of the HEMOTAG® system in a less controlled environment and concurrently develop the system for use by patients with heart failure.
Gender:
All
Ages:
22 years and above
Trial Updated:
08/11/2023
Locations: Cleveland Clinic Florida, Weston, Florida
Conditions: Heart Failure (HF)
Register for Updates